Blood concentrations of bile acids are elevated in patients with non-alcoholic fatty liver disease (NAFLD) who exhibit insulin resistance (61), and inositol, with its insulin-mimetic properties, can play a role in diseases associated with insulin resistance and has the potential to modulate NAFLD (62). Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.